We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Reasons Why Investors Should Consider Investing in IDEX Stock
Read MoreHide Full Article
Key Takeaways
IDEX lifted its 2026 organic sales growth forecast to 5-6% as HST backlog and industrial demand improved.
HST organic sales rose 12% and orders jumped 47%, extending IDEX's backlog visibility into 2027.
IDEX paid $106.7M in dividends and repurchased $153.4M of shares in the first half of 2026.
IDEX Corporation (IEX - Free Report) is well-poised to benefit from strength across its business, acquisitions, focus on improving the product line and operational excellence. The company remains focused on investing in growth opportunities and solidifying its long-term market position.
IEX has a market capitalization of $16.4 billion and currently carries a Zacks Rank #2 (Buy). Let’s delve into the factors that have been aiding the firm for a while now.
Business Strength: IDEX is benefiting from healthy demand across data center, semiconductor, space and defense markets within the Health & Science Technologies (HST) segment. In second-quarter 2026, the HST segment’s organic sales rose 12% and organic orders increased 47%, extending backlog visibility into 2027.
Fluid & Metering Technologies (FMT) segment recorded a 1% increase in organic sales, while orders climbed 11%, supported by solid demand across the municipal water and mining markets. The company also lifted its 2026 organic sales growth forecast to 5-6% from the previous 3-4% range, citing a stronger HST order backlog and improving demand trends in its industrial operations.
Acquisition Benefits: The company continues to add assets that expand capabilities and geographic reach. In second-quarter 2026, acquisitions added 1% to consolidated sales growth and 2% to HST sales growth, reflecting Micro-LAM, acquired in July 2025. The Micro-LAM buyout boosted IEX’s proficiency in materials science domain and expanded its optics technologies offerings within the HST segment. It also strengthened its presence across aerospace, defense and optics industries.
Price Performance of IEX
Image Source: Zacks Investment Research
In the past year, IDEX has gained 39.2% compared with the industry’s 0.4% growth.
Shareholder-Friendly Policies: It remains committed to rewarding its shareholders through dividend payouts and share buybacks. In the first six months of 2026, IDEX paid out dividends worth $106.7 million and repurchased shares worth $153.4 million. In September 2025, the company’s board increased the share repurchase authorization to $1 billion. Exiting the second quarter, IDEX had a remaining balance of $774.7 million under its share repurchase program.
Earnings Estimates: The Zacks Consensus Estimate for IEX’s 2026 earnings is pegged at $8.83 per share, indicating an increase of 11.1% on a year-over-year basis. The consensus estimate for 2027 earnings is pegged at $9.64 per share, indicating an increase of 9.2% from the previous year.
Other Stocks to Consider
Some other top-ranked companies from the same space are discussed below.
Generac Holdings surpassed the consensus estimate twice and missed in the other two of the trailing four quarters. GNRC delivered a trailing four-quarter average earnings surprise of 13.7%. In the past 60 days, the Zacks Consensus Estimate for Generac Holdings’ 2026 earnings has increased 8.6%.
Helios Technologies (HLIO - Free Report) currently carries a Zacks Rank of 2. Helios Technologies’ earnings topped the consensus estimate in each of the trailing four quarters. The average earnings surprise was 13.1%. In the past 60 days, the Zacks Consensus Estimate for HLIO’s 2026 earnings has increased 10.4%.
RBC Bearings Incorporated (RBC - Free Report) presently carries a Zacks Rank of 2. RBC Bearings’ earnings topped the consensus estimate in each of the trailing four quarters. The average earnings surprise was 8.7%. The Zacks Consensus Estimate for RBC’s fiscal 2027 (ending March 2027) earnings has increased 4.9% over the past 60 days.
Image: Bigstock
Reasons Why Investors Should Consider Investing in IDEX Stock
Key Takeaways
IDEX Corporation (IEX - Free Report) is well-poised to benefit from strength across its business, acquisitions, focus on improving the product line and operational excellence. The company remains focused on investing in growth opportunities and solidifying its long-term market position.
IEX has a market capitalization of $16.4 billion and currently carries a Zacks Rank #2 (Buy). Let’s delve into the factors that have been aiding the firm for a while now.
Business Strength: IDEX is benefiting from healthy demand across data center, semiconductor, space and defense markets within the Health & Science Technologies (HST) segment. In second-quarter 2026, the HST segment’s organic sales rose 12% and organic orders increased 47%, extending backlog visibility into 2027.
Fluid & Metering Technologies (FMT) segment recorded a 1% increase in organic sales, while orders climbed 11%, supported by solid demand across the municipal water and mining markets. The company also lifted its 2026 organic sales growth forecast to 5-6% from the previous 3-4% range, citing a stronger HST order backlog and improving demand trends in its industrial operations.
Acquisition Benefits: The company continues to add assets that expand capabilities and geographic reach. In second-quarter 2026, acquisitions added 1% to consolidated sales growth and 2% to HST sales growth, reflecting Micro-LAM, acquired in July 2025. The Micro-LAM buyout boosted IEX’s proficiency in materials science domain and expanded its optics technologies offerings within the HST segment. It also strengthened its presence across aerospace, defense and optics industries.
Price Performance of IEX
Image Source: Zacks Investment Research
In the past year, IDEX has gained 39.2% compared with the industry’s 0.4% growth.
Shareholder-Friendly Policies: It remains committed to rewarding its shareholders through dividend payouts and share buybacks. In the first six months of 2026, IDEX paid out dividends worth $106.7 million and repurchased shares worth $153.4 million. In September 2025, the company’s board increased the share repurchase authorization to $1 billion. Exiting the second quarter, IDEX had a remaining balance of $774.7 million under its share repurchase program.
Earnings Estimates: The Zacks Consensus Estimate for IEX’s 2026 earnings is pegged at $8.83 per share, indicating an increase of 11.1% on a year-over-year basis. The consensus estimate for 2027 earnings is pegged at $9.64 per share, indicating an increase of 9.2% from the previous year.
Other Stocks to Consider
Some other top-ranked companies from the same space are discussed below.
Generac Holdings (GNRC - Free Report) currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Generac Holdings surpassed the consensus estimate twice and missed in the other two of the trailing four quarters. GNRC delivered a trailing four-quarter average earnings surprise of 13.7%. In the past 60 days, the Zacks Consensus Estimate for Generac Holdings’ 2026 earnings has increased 8.6%.
Helios Technologies (HLIO - Free Report) currently carries a Zacks Rank of 2. Helios Technologies’ earnings topped the consensus estimate in each of the trailing four quarters. The average earnings surprise was 13.1%. In the past 60 days, the Zacks Consensus Estimate for HLIO’s 2026 earnings has increased 10.4%.
RBC Bearings Incorporated (RBC - Free Report) presently carries a Zacks Rank of 2. RBC Bearings’ earnings topped the consensus estimate in each of the trailing four quarters. The average earnings surprise was 8.7%. The Zacks Consensus Estimate for RBC’s fiscal 2027 (ending March 2027) earnings has increased 4.9% over the past 60 days.